当前位置: X-MOL 学术Int. J. Epidemiol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Increased risk of subsequent antiphospholipid syndrome in patients with endometriosis.
International Journal of Epidemiology ( IF 6.4 ) Pub Date : 2024-12-16 , DOI: 10.1093/ije/dyae167
Zhiyong Chen,Ran Cui,Shiow-Ing Wang,Hua Zhang,Miao Chen,Qian Wang,Qiang Tong,James Cheng-Chung Wei,Sheng-Ming Dai

BACKGROUND Although autoimmune abnormalities are common in patients with endometriosis, it is unknown whether patients with endometriosis have a higher risk of developing antiphospholipid syndrome (APS). METHODS We conducted a retrospective cohort study by using the multi-institutional research network TriNetX from 1 January 2012 to 31 December 2021. A total of 13 131 782 women aged 20-60 years from networks within the USA were included. The risks of APS were compared between an endometriosis cohort and a non-endometriosis cohort in subgroup analyses by age, obesity and systemic lupus erythematosus (SLE), and the sensitivity analysis was stratified by the presence or absence of a history of surgery of the uterus. RESULTS After 1:1 propensity score matching, the endometriosis and non-endometriosis cohorts each included 50 078 participants. Compared to individuals without endometriosis, patients with endometriosis had a higher risk of incident APS (log-rank test, P < 0.001). The hazard ratios (HRs) ranged from 1.82 [APS within 30 days to 1 year after the index date, 95% confidence intervals (CIs) 1.40-2.53] to 2.44 (APS within 30 days to any time after the index date, 95% CI 1.65-3.61). In the subgroup analyses, an increased risk of APS was observed in all ages, White race, and subgroups without smoking, obesity, asthma, inflammatory bowel disease and SLE (HR range 1.85-2.84). Sensitivity analyses revealed that the risk of APS increased in patients without surgery history of the uterus. CONCLUSIONS Patients with endometriosis had a higher risk (2.84-fold) of developing APS. Future large-scale prospective studies are warranted to confirm our results.

中文翻译:


子宫内膜异位症患者随后发生抗磷脂综合征的风险增加。



背景 尽管自身免疫异常在子宫内膜异位症患者中很常见,但尚不清楚子宫内膜异位症患者发生抗磷脂综合征 (APS) 的风险是否更高。方法 我们于 2012 年 1 月 1 日至 2021 年 12 月 31 日使用多机构研究网络 TriNetX 进行了一项回顾性队列研究。共纳入了来自美国网络的 13 131 782 名年龄在 20-60 岁之间的女性。在亚组分析中,按年龄、肥胖和系统性红斑狼疮 (SLE) 比较子宫内膜异位症队列和非子宫内膜异位症队列之间的 APS 风险,并根据是否存在子宫手术史对敏感性分析进行分层。结果 1:1 倾向评分匹配后,子宫内膜异位症和非子宫内膜异位症队列各包括 50 078 名参与者。与无子宫内膜异位症的个体相比,子宫内膜异位症患者发生 APS 的风险更高 (log-rank 检验,P < 0.001)。风险比 (HRs) 范围为 1.82 [索引日期后 30 天内至 1 年的 APS,95% 置信区间 (CIs) 1.40-2.53] 至 2.44 (索引日期后 30 天内的 APS,95% CI 1.65-3.61)。在亚组分析中,在所有年龄、白种人和无吸烟、肥胖、哮喘、炎症性肠病和 SLE 的亚组中观察到 APS 风险增加 (HR 范围 1.85-2.84)。敏感性分析显示,无子宫手术史的患者发生 APS 的风险增加。结论 子宫内膜异位症患者发生 APS 的风险更高 (2.84 倍)。未来需要进行大规模的前瞻性研究来证实我们的结果。
更新日期:2024-12-16
down
wechat
bug